Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00379470
Recruitment Status : Completed
First Posted : September 21, 2006
Last Update Posted : May 1, 2012
Information provided by (Responsible Party):
NovoCure Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2009
  Study Completion Date : January 2011
Publications automatically indexed to this study by Identifier (NCT Number):